Cytek Biosciences, Inc. · NASDAQ:CTKB
Jiang Wenbin exercised options for 120,095 Cytek Biosciences, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Jiang Wenbin (Director, PRESIDENT AND CEO) exercised options for 120,095 Cytek Biosciences, Inc. shares, leaving 5,561,029 shares. Filed Aug 20, 2026 (Form 4).
- Options exercised
- 120,095 shares
- Holding after
- 5,561,029 shares
- Trading plan
- No
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Option exercise | 11,781 | 5,488,984 | Direct | |
| Aug 18, 2026 | Common Stock | Shares withheld for tax | 2,869 | US$4.67 | 5,486,115 | Direct |
| Aug 18, 2026 | Common Stock | Option exercise | 22,100 | 5,508,215 | Direct | |
| Aug 18, 2026 | Common Stock | Shares withheld for tax | 5,382 | US$4.67 | 5,502,833 | Direct |
| Aug 18, 2026 | Common Stock | Option exercise | 29,002 | 5,531,835 | Direct | |
| Aug 18, 2026 | Common Stock | Shares withheld for tax | 7,062 | US$4.67 | 5,524,773 | Direct |
| Aug 18, 2026 | Common Stock | Option exercise | 57,212 | 5,581,985 | Direct | |
| Aug 18, 2026 | Common Stock | Shares withheld for tax | 20,956 | US$4.67 | 5,561,029 | Direct |